European Alliance of Associations for Rheumatology (EULAR) 2025 is organized by European Alliance of Associations for Rheumatology (EULAR) and will be held from Jun 11 - 14, 2025 at Barcelona Fair, Barcelona, Barcelona, Spain.
Description:
The aim of the European Congress of Rheumatology is to provide a forum of the highest standard for scientific (both clinical and basic), educational and social exchange between professionals involved in rheumatology, liaising with patient organisations, in order to achieve progress in the clinical care of people with rheumatic diseases.
The EULAR European Congress of Rheumatology is our esteemed flagship event, consistently delivering an unparalleled experience year after year. The Congress serves as a unifying platform where individuals with RMDs, esteemed health professionals, dedicated rheumatologists, and respected industry partners come together to explore the latest scientific breakthroughs and practical advancements in the field of rheumatology. Our Congress is crafted to connect groundbreaking research with practical application, ensuring a seamless transition from diagnosis to patient care through hands-on workshops and innovative sessions.
The EULAR 2025 Scientific Programme is carefully curated to tackle the key challenges and explore emerging opportunities in the field. Attendees will have the chance to deepen their knowledge, share ideas, and build valuable connections with peers from around the globe.
Note:
The EULAR On-Demand Platform will be available from Monday, 16 June until Wednesday, 31 December 2025.
Accreditation
The EULAR 2024 Congress was awarded with 22.5 CME credits by EACCME. We will apply for EACCME accreditation for EULAR 2025 in due time.
Certificate of attendance (COA) showing CME credits granted at EULAR 2025 will be available for download and given to delegates who attended the onsite congress in Barcelona. Registered participants who are not attending the congress will not be eliable to the certificate of attendance.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved